Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: Results from ERCHIVES

Alimentary Pharmacology and Therapeutics

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2aPW2a5
via IFTTT